BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sterclova M, Vasakova M. Promising new treatment targets in patients with fibrosing lung disorders. World J Clin Cases 2014; 2(11): 668-675 [PMID: 25405190 DOI: 10.12998/wjcc.v2.i11.668]
URL: https://www.wjgnet.com/2307-8960/full/v2/i11/668.htm
Number Citing Articles
1
Jacopo Di Gregorio, Iole Robuffo, Sonia Spalletta, Giulia Giambuzzi, Vincenzo De Iuliis, Elena Toniato, Stefano Martinotti, Pio Conti, Vincenzo Flati. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic DisordersFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.607483
2
Daniele Magnini, Giuliano Montemurro, Bruno Iovene, Linda Tagliaboschi, Rafael Emanuele Gerardi, Erminia Lo Greco, Teresa Bruni, Alessio Fabbrizzi, Francesco Lombardi, Luca Richeldi. Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging TherapiesRespiration 2017; 93(6): 379 doi: 10.1159/000475780
3
Xinyuan Zhao, Saisai Wei, Zhijian Li, Chen Lin, Zhenfeng Zhu, Desen Sun, Rongpan Bai, Jun Qian, Xiangwei Gao, Guangdi Chen, Zhengping Xu. Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosisCell Death & Disease 2019; 10(2) doi: 10.1038/s41419-019-1340-8